Literature DB >> 26860671

Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance.

Clara Bonanad1, Jose V Monmeneu2, Maria P Lopez-Lereu2, Arantxa Hervas1, Elena de Dios1, Jose Gavara1, Julio Nunez1, Gema Minana1, Oliver Husser1, Ana Paya1, Paolo Racugno1, Sergio García-Blas1, Francisco J Chorro1, Vicente Bodi3.   

Abstract

BACKGROUND: Cardiovascular magnetic resonance (CMR) predicts combined clinical events in post-ST-segment elevation myocardial infarction (STEMI) patients. However, its contribution to predicting long-term major events (ME: cardiac death and non-fatal myocardial infarction [MI]) is unknown. We aimed to assess whether CMR predicts long-term MEs when performed soon after STEMI. METHODS AND
RESULTS: We prospectively recruited 546 STEMI patients between 2004 and 2012. The Left ventricular (LV) ejection fraction (LVEF,%), infarct size (IS), edema, hemorrhage, microvascular obstruction, and myocardial salvage were quantified by CMR at pre-discharge. During a mean follow-up of 840 days, 57 ME events (10%; 23 cardiac deaths, 34 non-fatal MIs) were documented. Patients with MEs has more depressed LVEFs (p<0.001), larger ISs (p<0.001), more extensive edema, hemorrhage, and microvascular obstruction, and lower myocardial salvage (p<0.05). CMR indexes were dichotomized according to the best cutoff values for predicting ME. In a comprehensive multivariate model, a LVEF<40% (HR: 2.3; 95% CI [12, 43]; p= 0.009) and an IS>30% of LV mass (HR: 2.4; 95% CI [13, 44]; p= 0.007) independently doubled the ME risk. The ME risk rates were 6%, 14%, and 30%, respectively (p<0.001) in patients with both the LVEF≥40% and an IS≤30% of LV mass (n=393), those with only one altered value (n=84), and in cases with both the LVEF<40% and an IS>30% of LV mass (n=69). Similar tendencies were observed regarding cardiac deaths (2%, 6%, 14%; p<0.001) and MI (4%, 8%, 16%; p < 0.001).
CONCLUSIONS: CMR performed soon after STEMI predicts long-term MEs. Combined analysis of CMR-derived LVEF and IS allows robust stratification of patient outcomes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Myocardial infarction; Prognosis

Mesh:

Year:  2015        PMID: 26860671     DOI: 10.1016/j.ejrad.2015.12.012

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Microvascular obstruction in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: another frontier to conquer?

Authors:  Islam Y Elgendy; Hani Jneid
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.

Authors:  Borja Ibanez; Anthony H Aletras; Andrew E Arai; Hakan Arheden; Jeroen Bax; Colin Berry; Chiara Bucciarelli-Ducci; Pierre Croisille; Erica Dall'Armellina; Rohan Dharmakumar; Ingo Eitel; Rodrigo Fernández-Jiménez; Matthias G Friedrich; David García-Dorado; Derek J Hausenloy; Raymond J Kim; Sebastian Kozerke; Christopher M Kramer; Michael Salerno; Javier Sánchez-González; Javier Sanz; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2019-07-16       Impact factor: 24.094

3.  Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study.

Authors:  Xiaoxiao Zhao; Chen Liu; Peng Zhou; Zhaoxue Sheng; Jiannan Li; Jinying Zhou; Runzhen Chen; Ying Wang; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Front Cardiovasc Med       Date:  2020-11-27

4.  A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.

Authors:  Min Ma; Ling Wang; Kai-Yue Diao; Shi-Chu Liang; Ye Zhu; Hua Wang; Mian Wang; Li Zhang; Zhi-Gang Yang; Yong He
Journal:  BMC Cardiovasc Disord       Date:  2022-02-04       Impact factor: 2.298

5.  Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion.

Authors:  Cesar Rios-Navarro; Jose Gavara; Veronica Vidal; Clara Bonanad; Paolo Racugno; Antoni Bayes-Genis; Gema Miñana; Oliver Husser; Ricardo Oltra; Julio Nuñez; Francisco J Chorro; Vicente Bodi; Amparo Ruiz-Sauri
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.